MLA
Donohue, James F, et al. Dose Selection for Glycopyrrolate/eflow® Phase Iii Clinical Studies: Results From Golden (glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) Phase Ii Dose-finding Studies. BioMed Central, 2017. https://doi.org/10.17615/qhkt-0s64
APA
Donohue, J., Goodin, T., Tosiello, R., & Wheeler, A. (2017). Dose selection for glycopyrrolate/eFlow® phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies. BioMed Central. https://doi.org/10.17615/qhkt-0s64
Chicago
Donohue, James F, Thomas Goodin, Robert Tosiello, and Alistair Wheeler. 2017. Dose Selection for Glycopyrrolate/eflow® Phase Iii Clinical Studies: Results From Golden (glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) Phase Ii Dose-Finding Studies. BioMed Central. https://doi.org/10.17615/qhkt-0s64